0001787792-26-000003.txt : 20260304 0001787792-26-000003.hdr.sgml : 20260304 20260304120217 ACCESSION NUMBER: 0001787792-26-000003 CONFORMED SUBMISSION TYPE: C-U PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260304 DATE AS OF CHANGE: 20260304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fisher Wallace Laboratories, Inc. CENTRAL INDEX KEY: 0001787792 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 208131183 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: C-U SEC ACT: 1933 Act SEC FILE NUMBER: 020-36769 FILM NUMBER: 26719786 BUSINESS ADDRESS: STREET 1: 515 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 917-930-4332 MAIL ADDRESS: STREET 1: 630 FLUSHING AVENUE, BOX 104 CITY: BROOKLYN STATE: NY ZIP: 11206 C-U 1 primary_doc.xml C-U 0001787792 XXXXXXXX 020-36769 LIVE false false false The Offering ended on February 20, 2026, having closed on $127,683.74 of funds although final accounting has yet to take place. Fisher Wallace Laboratories, Inc. Corporation DE 08-23-2019 630 FLUSHING AVENUE, BOX 104 BROOKLYN NY 11206 fisherwallace.com N DEALMAKER SECURITIES LLC 0001872856 008-70756 000315324 Up to 8.5% Common Stock 8921 11.21000 103504.56 Y Other At the discretion of the Company 2587498.09 02-20-2026 5.00 154382.00 361017.00 41626.00 311160.00 0.00 0.00 596720.00 569243.00 940656.00 866830.00 47412.00 2019527.00 3012.00 350736.00 0.00 0.00 -1579900.00 -1644382.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 Fisher Wallace Laboratories, Inc. /Kelly Roman/ Chief Executive Officer and Director /Kelly Roman/ Chief Executive Officer and Director 03-04-2026